Regulation of apoptosis by lethal cytokines in human mesothelial cells

Kidney International

Volumn 64, Issue 1, 2003, Pages 321-330

  Catalan, Marina Peniélope ^b   Subirá, Dolores ^b   Reyero, Ana ^b   Selgas, Rafael ^b   Ortiz Gonzalez, Arturo ^b   Egido, Jesús ^b   Ortiz, Alberto ^a  

^a Unidad de Dialisis   (Spain)

^b NONE

Author keywords

Apoptosis; Fas; Mesothelium; Peritoneal dialysis; TNF; TRAIL

Indexed keywords

CYTOKINE; FAS LIGAND; MESSENGER RNA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; MESOTHELIUM CELL; NUCLEOTIDE SEQUENCE; PERITONEAL DIALYSIS; PERITONEUM CELL; PERITONITIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 0012787697     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00062.x     Document Type: Article

References (36)

1. DI POALO N, SACCHI G: Atlas of peritoneal histology. Perit Dial Int 20(Suppl 3):S5-S96, 2000
2. ORTIZ A: Apoptotic regulatory proteins in renal injury. Kidney Int 58:467-485, 2000
3. YANG AH, CHEN JY, LIN YP, et al: Peritoneal dialysis solution induces apoptosis of mesothelial cells. Kidney Int 51:1280-1288, 1997
4. LOCKSLEY RM, KILLEEN N, LENARDO MJ: The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104:487-501, 2001
5. ZEMEL D, IMHOLZ AL, DE WAART DR, et al: Appearance of tumor necrosis factor-alpha and soluble TNF-receptors I and II in peritoneal effluent of CAPD. Kidney Int 46:1422-1430, 1994
6. ORTiZ A, LORZ C, EGIDO J: New kids in the block: The role of FasL and Fas in kidney damage. J Nephrol 12:150-158, 1999
7. LORZ C, ORTIZ A, JUSTO P, et al: Proapoptotic Fas ligand is expressed by normal kidney tubular epithelium and injured glomeruli. J Am Soc Nephrol 11:1266-1277, 2000
8. SATA M, SUHARA T, WALSH K: Vascular endothelial cells and smooth muscle cells differ in expression of Fas and Fas ligand and in sensitivity to Fas ligand-induced cell death: Implications for vascular disease and therapy. Arterioscler Thromb Vasc Biol 20:309-316, 2000
9. DIAZ C, SELGAS R, CASTRO MA, et al: Ex-vivo proliferation of mesothelial cells directly obtained from peritoneal effluent. Its relationship with peritoneal antecedents and functional parameters. Adv Perit Dial 14:19-24, 1998
10. ORTIZ A, LORZ C, CATALÁN MP, et al: Expression of apoptosis regulatory proteins in tubular epithelium stressed in culture or following acute renal failure. Kidney Int 57:969-981, 2000
11. ORTIZ A, GONZALEZ-CUADRADO S, LORZ C, et al: Cytokines and Fas regulate apoptosis in murine renal interstitial fibroblasts. J Am Soc Nephrol 8:1845-1854, 1997
12. GONZÁLEZ-CUADRADO S, LÓPEZ-ARMADA MJ, GÓMEZ-GUERRERO C, et al: Anti-Fas antibodies induce cytolysis and apoptosis in cultured human mesangial cells. Kidney Int 49:1064-1070, 1996
13. TAKAHASHI T, TANAKA M, INAZAWA J, et al: Human Fas ligand: Gene structure, chromosomal location and species specificity. Int Immunol 6:1567-1574, 1994
14. ITOH N, YONEHARA S, ISHII A, et al: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233-243, 1991
15. PAN G, O'ROURKE K, CHINNAIYAN AM, et al: The receptor for the cytotoxic ligand TRAIL. Science 276:111-113, 1997
16. MACFARLANE M, AHMAD M, SRINIVASULA SM, et al: identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL. J Biol Chem 272:25417-25420, 1997
17. WILEY SR, SCHOOLEY K, SMOLAK PJ, et al: Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673-682, 1995
18. PAN G, NI J, WEI YF, et al: An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277:815-818, 1997
19. DASGUPTA MK, LARABIE M, HALLORAN PF: Interferon-gamma levels in peritoneal dialysis effluents: Relation to peritonitis. Kidney Int 46:475-481, 1994
20. GOTLOIB L, SHOSTAK A, WAJSBROT V, KUSHNIER R: High glucose induces a hypertrophic, senescent mesothelial cell phenotype after long in vivo exposure. Nephron 82:164-173, 1999
21. ZHENG Z, YE R, Yu X, et al: Peritoneal dialysis solutions disturb the balance of apoptosis and proliferation of peritoneal cells in chronic dialysis model. Adv Perit Dial 17:53-57, 2001
22. CATALÁN MP, ESTEBAN J, SUBIRÁ D, et al: Inhibition of caspases improves bacterial clearance in experimental peritonitis. Perit Dial Int 23:123-126, 2003
23. SAVILL J: Apoptosis in post-streptococcal glomerulonephritis. Kidney Int 60:1203-1214, 2001
24. CATALÁN MP, REYERO A, EGIDO J, ORTIZ A: Acceleration of neutrophil apoptosis by glucose-containing peritoneal dialysis solutions: Role of caspases. J Am Soc Nephrol 12:2442-2449, 2001
25. ORTIZ A, GONZALEZ-CUADRADO S, BUSTOS C, et al: Tumor necrosis factor and glomerular damage. J Nephrol 8:27-34, 1995
26. ALEXANDER EH, BENTO JL, HUGHES FM, JR, et al: Staphylococcus aureus and Salmonella enterica serovar Dublin induce tumor necrosis factor-related apoptosis-inducing ligand expression by normal mouse and human osteoblasts. Infect Immun 69:1581-1586, 2001
27. ZHENG ZH, YE RG, BERGSTROM J, LINDHOLM B: Effect of dialysate composition on the apoptosis and proliferation of human peritoneal mesothelial cells and protein expression of Fas and c-Myc. Adv Perit Dial 16:321-35, 2000
28. SATA M, WALSH K: Endothelial cell apoptosis induced by oxidized LDL is associated with the down-regulation of the cellular caspase inhibitor FLIP. J Biol Chem 273:33103-33107, 1998
29. GOCHUICO BR, ZHANG J, MA BY, et al: TRAIL expression in vascular smooth muscle. Am J Physiol Lung Cell Mol Physiol 278:L1045-L1050, 2000
30. SCHNEIDER P, THOME M, BURNS K, et al: TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB. Immunity 7:831-836, 1997
31. ANDREOLA G, RIVOLTINI L, CASTELLI C, et al: Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. J Exp Med 195:1303-1316, 2002
32. SATA M, WALSH K: TNFalpha regulation of Fas ligand expression on the vascular endothelium modulates leukocyte extravasation. Nat Med 4:415-420, 1998
33. LILES WC, KIENER PA, LEDBETTER JA, et al: Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: Implications for the regulation of apoptosis in neutrophils. J Exp Med 184:429-440, 1996
34. MOGI M, FUKUO K, YANG J, et al: Hypoxia stimulates release of the soluble form of fas ligand that inhibits endothelial cell apoptosis. Lab Invest 85:177-184, 2001
35. HOTCHKISS RS, TINSLEY KW, SWANSON PE, et al: Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc Natl Acad Sci USA 96:14541-14546, 1999
36. RODRIGUEZ I, MATSUURA K, ODY C, et al: Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death. J Exp Med 184:2067-2072, 1996